Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crohn's disease: the case for bacteria.

C Prantera1, M L Scribano

  • 1Division of Gastroenterology, Nuovo Regina Margherita Hospital, Rome, Italy.

Italian Journal of Gastroenterology and Hepatology
|June 24, 1999
PubMed
Summary

While Crohn's disease isn't definitively bacterial, evidence suggests bacteria may contribute. Further research is needed to explore the role of gut bacteria in Crohn's disease pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial.

European review for medical and pharmacological sciences·2020
Same author

Letter: budesonide MMX for ulcerative colitis?

Alimentary pharmacology & therapeutics·2014
Same author

Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.

Alimentary pharmacology & therapeutics·2009
Same author

Cerebral tubercular lesions in a patient treated with infliximab for Crohn's disease.

Journal of neurology·2008
Same author

Antibiotic use in Crohn's disease: why and how?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.

Alimentary pharmacology & therapeutics·2007

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • Crohn's disease etiology remains incompletely understood.
  • A long-standing hypothesis suggests a potential link between mycobacteria and Crohn's disease.
  • Several observations support a role for bacteria in intestinal inflammation.

Purpose of the Study:

  • To evaluate the evidence for a bacterial cause of Crohn's disease.
  • To assess the applicability of Bradford Hill criteria to the mycobacteria-Crohn's disease hypothesis.
  • To explore potential mechanisms by which bacteria might contribute to Crohn's disease.

Main Methods:

  • Review of experimental and clinical observations regarding intestinal inflammation and bacteria.
  • Application of Bradford Hill criteria to assess causality between mycobacteria and Crohn's disease.
  • Analysis of the role of luminal content and antibiotic treatment in Crohn's disease.

Main Results:

  • Germ-free animals do not develop intestinal inflammation, indicating a role for microbes.
  • Antibiotic use shows success in treating Crohn's disease, suggesting a bacterial involvement.
  • Only biological plausibility, coherence, and analogy criteria are met for mycobacteria causality.

Conclusions:

  • A definitive bacterial cause for Crohn's disease has not been established.
  • Failure to identify a specific pathogen does not rule out bacterial involvement.
  • Commensal or pathogenic enteric bacteria may exacerbate inflammation in susceptible individuals, or gut flora may acquire pathogenic traits.

Related Experiment Videos